Leo Groenewegen
Director Ejecutivo en NBAB, Nordic BioAnalysis AB .
Perfil
Leo Groenewegen is currently the Chief Executive Officer at NBAB, Nordic BioAnalysis AB.
Prior to this, he worked as the Chief Financial Officer at NextCell Pharma AB.
Cargos activos de Leo Groenewegen
| Empresas | Cargo | Inicio |
|---|---|---|
NBAB, Nordic BioAnalysis AB
 NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Part of Ilya Pharma AB, NBAB, Nordic BioAnalysis AB engages in bio analytical development, validation and analysis of medicines. The company is based in Södertälje, Sweden. The Swedish company was founded in 2010. The CEO is Leo Groenewegen. NBAB was acquired by Ilya Pharma AB on April 19, 2022. | Director Ejecutivo | 01/09/2022 |
Antiguos cargos conocidos de Leo Groenewegen.
| Empresas | Cargo | Fin |
|---|---|---|
| NEXTCELL PHARMA AB | Director Financiero/CFO | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NEXTCELL PHARMA AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
NBAB, Nordic BioAnalysis AB
NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Part of Ilya Pharma AB, NBAB, Nordic BioAnalysis AB engages in bio analytical development, validation and analysis of medicines. The company is based in Södertälje, Sweden. The Swedish company was founded in 2010. The CEO is Leo Groenewegen. NBAB was acquired by Ilya Pharma AB on April 19, 2022. | Health Technology |
- Bolsa de valores
- Insiders
- Leo Groenewegen
